NVRO | Nevro Corp. Stock Overview

(Stock Exchange: NYSE)

Day's Range	4.06 - 4.26
52 Week Range	3.95 - 22.64
Beta	0.83
Implied Volatility	241.95%
IV Rank	74.42%
Day's Volume	260,180
Average Volume	534,860
Shares Outstanding	37,471,600
Market Cap	158,130,152
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2014-11-06

Valuation
Profitability
Growth
Health
P/E Ratio	-2.26
Forward P/E Ratio	N/A
EPS	-1.87
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,215
Country	USA
Website	NVRO

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

NVRO's peers: AVNS, GKOS, GMED, ICAD, ITGR, MASS, NPCE, NUVA, CNMD, LUNG, IRMD, OFIX, KIDS, SGHT, CVRX, RXST, FNA, OSA, LIVN, ELMD, SRDX, OM, PROF, RBOT, VREX

*Chart delayed

Analyzing fundamentals for NVRO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see NVRO Fundamentals page.

Watching at NVRO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on NVRO Technicals page.